Rxmed Pharmaceutical Private Limited
About Rxmed Pharmaceutical Private Limited
Data last updated:
Rxmed Pharmaceutical Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 June 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497HR2023PTC112624.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Madhu and Kajal Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gurgaon, Haryana.
As per the financials filed for FY 2024, the company reported a revenue of ₹27,700. For the same year it recorded a net loss of ₹75,400 (net margin -272.2%) and EBITDA of -₹74,800 (EBITDA margin -270%).
Company details
Contact details
Rxmed Pharmaceutical Private Limited's registered office is in Gurgaon, Haryana.
- Registered AddressShop No. 2, Dayanand Colony, Gurgaon, Haryana, India – 122001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rxmed Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Rxmed Pharmaceutical Private Limited, buy the company report.
Financials of Rxmed Pharmaceutical Private Limited
FY 2025 filings availableRxmed Pharmaceutical Private Limited reported revenue of ₹27,700 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹74,800 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹75,400 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | -270% |
| Net Profit Margin | -272.2% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Rxmed Pharmaceutical Private Limited, buy the company report.
Board of directors of Rxmed Pharmaceutical Private Limited
Rxmed Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu | Director | 19 Jun 2023 | 3 Years 4 Months | Current |
| Kajal Singh | Director | 19 Jun 2023 | 3 Years 4 Months | Current |
Peer comparison
Rxmed Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Favourite Oils & Chemicals Suppliers Private Limited | ₹28,500 (FY 2024) | 451.0% | Kolkata, West Bengal, India | |||
| Learnbridge Library Private Limited | ₹28,452 (FY 2025) | -76.0% | Teori, Rajasthan, India | |||
| Malliamma Silks Private Limited | ₹28,392 (FY 2025) | Sriperumbudur, Tamil Nadu, India | ||||
| Cavemark Publications Private Limited | ₹28,383 (FY 2025) | -15.0% | Lucknow, Uttar Pradesh, India | |||
| Techgram Systems India Private Limited | ₹28,076 (FY 2025) | 5585.0% | Mumbai, Maharashtra, India | |||
| Rxmed Pharmaceutical Private Limitedthis company | ₹27,700 (FY 2024) | -₹75,400 | -272.2% | Gurgaon, Haryana, India | ||
| Hazra Buildcon Private Limited | ₹27,560 (FY 2024) | 5.0% | Karanjali, West Bengal, India | |||
| Cistela Pharma Private Limited | ₹27,500 (FY 2025) | -95.0% | North Lakhimpur, Assam, India | |||
| Grahlakshmi Khadya Udyog Private Limited | ₹27,381 (FY 2025) | New Delhi, Delhi, India | ||||
| Munaar Dealers Private Limited | ₹27,380 (FY 2025) | -4.0% | Kolkata, West Bengal, India | |||
| Smilekey Private Limited | ₹27,333 (FY 2025) | Chandigarh, India |
To see the full peer comparison of Rxmed Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rxmed Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rxmed Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rxmed Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rxmed Pharmaceutical Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Kajal Singh was appointed as Director on 19 Jun 2023.
Frequently asked questions
Rxmed Pharmaceutical is an active private limited company based in Gurgaon, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 June 2023 (3+ years old) and is registered under CIN U46497HR2023PTC112624.
Rxmed Pharmaceutical has 2 current directors:
- Madhu - Director
- Kajal Singh - Director
The latest financial statements of Rxmed Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Rxmed Pharmaceutical is U46497HR2023PTC112624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rxmed Pharmaceutical was incorporated on 19 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rxmed Pharmaceutical by revenue are Favourite Oils & Chemicals Suppliers Private Limited, Learnbridge Library Private Limited, Malliamma Silks Private Limited, Cavemark Publications Private Limited, Techgram Systems India Private Limited and 5 more, all in the same principal business activity (retail trade, except of motor vehicles and motorcycles).
Kajal Singh was appointed as Director on 19 Jun 2023. Madhu was appointed as Director on 19 Jun 2023.
The registered office of Rxmed Pharmaceutical is at Shop No. 2, Dayanand Colony, Gurgaon, Haryana, India – 122001.
Rxmed Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Rxmed Pharmaceutical can be reached at its registered office: Shop No. 2, Dayanand Colony, Gurgaon, Haryana, India – 122001.
Rxmed Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
